Hans E. Huber
Impact in
- Virology top 2%
- Molecular Biology top 2%
- PI3K/AKT/mTOR signaling in cancer
- DNA Repair Mechanisms
- DNA and Nucleic Acid Chemistry
- Ubiquitin and proteasome pathways
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 9
- Protein Kinase Regulation and GTPase Signaling 7
- Oncology 17
- Cancer-related Molecular Pathways 10
- Co-authors
- Carolyn C. Richardson (6 shared papers)Stanley Tabor (2 shared papers)Deborah Defeo-Jones (15 shared papers)Raymond E. Jones (12 shared papers)R. Robinson (19 shared papers)Stanley F. Barnett (11 shared papers)George D. Hartman (17 shared papers)Pearl S. Huang (6 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (18 papers)Journal of Biological Chemistry (10 papers)Molecular and Cellular Biology (6 papers)Journal of Medicinal Chemistry (3 papers)Gene (3 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Hans E. Huber
73 papers receiving 5.1k citations
Peers
Comparison fields: 5 of 105
- Virology 311
- Molecular Biology 3.6k
- Cell Biology 631
- Oncology 949
- Organic Chemistry 940
Countries citing papers authored by Hans E. Huber
This map shows the geographic impact of Hans E. Huber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans E. Huber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans E. Huber more than expected).
Fields of papers citing papers by Hans E. Huber
This network shows the impact of papers produced by Hans E. Huber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans E. Huber. The network helps show where Hans E. Huber may publish in the future.
Co-authors
The 25 scholars most cited alongside Hans E. Huber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 448 | |
| 2 | 1987 | 359 | |
| 3 | 2005 | 348 | |
| 4 | 1991 | 295 | |
| 5 | 1989 | 226 | |
| 6 | 1987 | 185 | |
| 7 | 2003 | 183 | |
| 8 | 1993 | 172 | |
| 9 | 2005 | 154 | |
| 10 | 2010 | 152 | |
| 11 | 2008 | 149 | |
| 12 | 2020 | 144 | |
| 13 | 1986 | 136 | |
| 14 | 2005 | 135 | |
| 15 | 2005 | 132 | |
| 16 | 1993 | 115 | |
| 17 | 1999 | 108 | |
| 18 | 1990 | 106 | |
| 19 | 1993 | 105 | |
| 20 | 2017 | 100 |
About Hans E. Huber
Hans E. Huber is a scholar working on Molecular Biology, Oncology, Genetics, Organic Chemistry and Cell Biology, having authored 74 papers that have together received 5.3k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (10 papers), Virus-based gene therapy research (10 papers), PI3K/AKT/mTOR signaling in cancer (9 papers), Quinazolinone synthesis and applications (9 papers), Microtubule and mitosis dynamics (8 papers), Protein Kinase Regulation and GTPase Signaling (7 papers), Synthesis and Biological Evaluation (6 papers) and Bacterial Genetics and Biotechnology (5 papers). The work is most often cited by research in Virology (311 citations), Molecular Biology (3.6k citations), Cell Biology (631 citations), Oncology (949 citations) and Organic Chemistry (940 citations). Hans E. Huber has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Carolyn C. Richardson, Stanley Tabor, Deborah Defeo-Jones, Raymond E. Jones, R. Robinson, Stanley F. Barnett, George D. Hartman, Pearl S. Huang, David C. Heimbrook and Paula J. Goodhart. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Biological Chemistry, Molecular and Cellular Biology, Journal of Medicinal Chemistry and Gene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.